researchdrivelogo.jpg
Rising Investments: Global Medical Device Manufacturing Outsourcing Market Expected to Surpass $104.3 Million, Rising at 10.3% CAGR from 2019 to 2026 [215-Pages] | Exclusively Available at Research Dive
24 janv. 2022 09h00 HE | Research Dive
New York, USA, Jan. 24, 2022 (GLOBE NEWSWIRE) -- A new report on the global medical device manufacturing outsourcing market has been added by Research Dive to its repository. According to the...
vmr logo registered_ blue.png
Optical Lens Market size worth $ 25,868.81 Million, Globally, by 2028 at 7.33% CAGR: Verified Market Research®
11 oct. 2021 09h15 HE | Verified Market Research
Jersey City, New Jersey, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Optical Lens Market” By Type (Converging Lenses and Diverging Lenses), By...
Graphical Research.jpg
Compounding Pharmacies Market Trends - Growth Forecasts 2026 | COVID-19 Impact Analysis: Graphical Research
16 févr. 2021 05h00 HE | Graphical Research
Pune, India, Feb. 16, 2021 (GLOBE NEWSWIRE) -- The global compounding pharmacies market size is anticipated to register substantial growth rate during the forecast period owing to growing...
ViGeneron_Logo_NEW.png
ViGeneron announces research collaboration with Daiichi Sankyo to evaluate vgAAV for novel ophthalmic gene therapy
18 janv. 2021 02h00 HE | ViGeneron GmbH
MUNICH, Germany, Jan. 18, 2021 (GLOBE NEWSWIRE) -- ViGeneron GmbH, a gene therapy company, today announced a research collaboration to utilize its novel engineered adeno-associated virus (vgAAV)...
ViGeneron_Logo_NEW.png
ViGeneron signs global collaboration agreement for ophthalmic gene therapy development
05 janv. 2021 02h00 HE | ViGeneron GmbH
Collaboration with Biogen to develop gene therapy for an undisclosed target to treat inherited eye disease, plus option for additional targetThe companies will use ViGeneron’s proprietary vgAAV...
fior-markets-logo.jpg
Global Compounding Pharmacies Market Is Expected to Reach USD 17.27 Billion by 2027 : Fior Markets
29 sept. 2020 01h00 HE | Fior Markets
Newark, NJ, Sept. 29, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global compounding pharmacies market is expected to grow from USD 10.44 billion in 2019 and to reach...
5c7ec11d9645b30004db9101_1.png
ADM Tronics to Develop Patented, Next-Generation Ophthalmic Diagnostic System for RetinalGeniX Technologies, Inc.
13 janv. 2020 09h54 HE | ADM Tronics Unlimited, Inc.
Northvale, NJ, Jan. 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT) announced that RetinalGeniX Technologies, Inc. (“RTI”), has entered into an engineering...
alimera.png
Alimera Sciences to Present at the 38th Annual Cowen & Co. Health Care Conference
27 févr. 2018 07h30 HE | Alimera Sciences, Inc.
ATLANTA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today...
GMILogo_Vertical-Gradient.png
Over-the-Counter Drugs Market to hit $178bn by 2024: Global Market Insights, Inc.
03 janv. 2018 02h00 HE | Global Market Insights, Inc
Sellbyville, Delaware, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Global OTC Drugs Market is estimated to surpass USD 178 billion by 2024; according to a new research report by Global Market Insights....
EYEN.png
Eyenovia, Inc. announces publication of Phase II study results demonstrating benefits of micro-formulation over conventional eyedroppers and addition of Scientific Advisory Board members
28 nov. 2016 15h46 HE | Eyenovia, Inc
Eyenovia’s study shows that conventional ophthalmic eye drops significantly overdose the eye and that equivalent, or greater, pharmacodynamic effect can be achieved with 80% less ocular exposure...